DOI QR코드

DOI QR Code

Surgical Outcomes of Cardiac Myxoma Resection Through Right Mini-Thoracotomy

  • Changwon Shin (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Min Ho Ju (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Chee-Hoon Lee (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Mi Hee Lim (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Hyung Gon Je (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine)
  • Received : 2022.08.30
  • Accepted : 2022.11.02
  • Published : 2023.01.05

Abstract

Background: With recent advances in cardiac surgery through minimal access, mini-thoracotomy has emerged as an excellent alternative for cardiac myxoma resection. This study analyzed the surgical results of this approach, focusing on postoperative cerebral embolism and tumor recurrence. Methods: We retrospectively reviewed 64 patients (mean age, 56.0±12.1 years; 40 women) who underwent myxoma resection through mini-thoracotomy from October 2008 to July 2020. We conducted femoral cannulation and antegrade cardioplegic arrest in all patients. Patient characteristics and perioperative data, including brain diffusion-weighted magnetic resonance imaging (DWI) findings, were collected. Medium-term echocardiographic follow-up was performed. Results: Thirteen patients (20.3%) had a history of preoperative stroke, and 7 (11.7%) had dyspnea with New York Heart Association functional class III or IV. Sixty-one cases (95.3%) had myxomas in the left atrium. The mean cardiopulmonary bypass and cardiac ischemic times were 69.0±28.6 and 34.1±15.0 minutes, respectively. Sternotomy conversion was not performed in any case, and 50 patients (78.1%) were extubated in the operating room. No early mortality or postoperative clinical stroke occurred. Postoperative DWI was performed in 32 (53%) patients, and 7 (22%) showed silent cerebral embolisms. One patient underwent reoperation for tumor recurrence during the study period; in that patient, a genetic study confirmed the Carney complex. Conclusion: Mini-thoracotomy for cardiac myxoma resection showed acceptable clinical and neurological outcomes. In the medium-term echocardiographic follow-up, reliable resection was proven, with few recurrences. This approach is a promising alternative for cardiac myxoma resection.

Keywords

Acknowledgement

This study was supported by Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital.

References

  1. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol 1996;77:107. https://doi.org/10.1016/s0002-9149(97)89149-7 
  2. Troccoli R, Lotti G. Frequency of primary and secondary tumors of the heart: (drawn from statistical findings collected in the Institute of Pathologic Anatomy and Histology of the University of Rome for the 10 year period 1953-1962). Ann Sanita Pubblica 1964;25:1467-73. 
  3. Elbardissi AW, Dearani JA, Daly RC, et al. Survival after resection of primary cardiac tumors: a 48-year experience. Circulation 2008;118(14 Suppl):S7-15. https://doi.org/10.1161/CIRCULATIONAHA.107.783126 
  4. Jimenez-Martinez M, Arguero-Sanchez R, Perez-Alvarez JJ, Mina-Castaneda P. Anterior mediastinitis as a complication of median sternotomy incisions: diagnostic and surgical considerations. Surgery 1970;67:929-34. 
  5. Heilmann C, Stahl R, Schneider C, et al. Wound complications after median sternotomy: a single-centre study. Interact Cardiovasc Thorac Surg 2013;16:643-8. https://doi.org/10.1093/icvts/ivs554 
  6. Pineda AM, Santana O, Cortes-Bergoderi M, Lamelas J. Is a minimally invasive approach for resection of benign cardiac masses superior to standard full sternotomy? Interact Cardiovasc Thorac Surg 2013;16:875-9. https://doi.org/10.1093/icvts/ivt063 
  7. Holzhey DM, Shi W, Borger MA, et al. Minimally invasive versus sternotomy approach for mitral valve surgery in patients greater than 70 years old: a propensity-matched comparison. Ann Thorac Surg 2011;91:401-5. https://doi.org/10.1016/j.athoracsur.2010.08.006 
  8. Lee HP, Cho WC, Kim JB, et al. Surgical outcomes of cardiac myxoma: right minithoracotomy approach versus median sternotomy approach. Korean J Thorac Cardiovasc Surg 2016;49:356-60. https://doi.org/10.5090/kjtcs.2016.49.5.356 
  9. Luo C, Zhu J, Bao C, Ding F, Mei J. Minimally invasive and conventional surgical treatment of primary benign cardiac tumors. J Cardiothorac Surg 2019;14:76. https://doi.org/10.1186/s13019-019-0890-2 
  10. Cheng DC, Martin J, Lal A, et al. Minimally invasive versus conventional open mitral valve surgery: a meta-analysis and systematic review. Innovations (Phila) 2011;6:84-103. https://doi.org/10.1097/IMI.0b013e3182167feb 
  11. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86:4041-6. https://doi.org/10.1210/jcem.86.9.7903 
  12. Bossert T, Gummert JF, Battellini R, et al. Surgical experience with 77 primary cardiac tumors. Interact Cardiovasc Thorac Surg 2005;4:311-5. https://doi.org/10.1510/icvts.2004.103044 
  13. Nordstrand IA, Tam RK. Minimally invasive surgery for cardiac myxomas using an upper hemi-sternotomy and biatrial septal approach. Heart Lung Circ 2005;14:255-61. https://doi.org/10.1016/j.hlc.2005.03.022 
  14. Schilling J, Engel AM, Hassan M, Smith JM. Robotic excision of atrial myxoma. J Card Surg 2012;27:423-6. https://doi.org/10.1111/j.1540-8191.2012.01478.x 
  15. Kesav P, John S, Joshi P, Gaba WH, Hussain SI. Cardiac myxoma embolization causing ischemic stroke and multiple partially thrombosed cerebral aneurysms. Stroke 2021;52:e10-4. https://doi.org/10.1161/STROKEAHA.120.031679 
  16. Desousa AL, Muller J, Campbell R, Batnitzky S, Rankin L. Atrial myxoma: a review of the neurological complications, metastases, and recurrences. J Neurol Neurosurg Psychiatry 1978;41:1119-24. https://doi.org/10.1136/jnnp.41.12.1119 
  17. Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol 2007;64:1115-20. https://doi.org/10.1001/archneur.64.8.1115 
  18. Lee SJ, Kim JH, Na CY, Oh SS. Eleven years' experience with Korean cardiac myxoma patients: focus on embolic complications. Cerebrovasc Dis 2012;33:471-9. https://doi.org/10.1159/000335830 
  19. Grossi EA, Loulmet DF, Schwartz CF, et al. Evolution of operative techniques and perfusion strategies for minimally invasive mitral valve repair. J Thorac Cardiovasc Surg 2012;143(4 Suppl):S68-70. https://doi.org/10.1016/j.jtcvs.2012.01.011 
  20. Saadat S, Schultheis M, Azzolini A, et al. Femoral cannulation: a safe vascular access option for cardiopulmonary bypass in minimally invasive cardiac surgery. Perfusion 2016;31:131-4. https://doi.org/10.1177/0267659115588631 
  21. Shah IK, Dearani JA, Daly RC, et al. Cardiac myxomas: a 50-year experience with resection and analysis of risk factors for recurrence. Ann Thorac Surg 2015;100:495-500. https://doi.org/10.1016/j.athoracsur.2015.03.007 
  22. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270-83. https://doi.org/10.1097/00005792-198507000-00007 
  23. Farah MG. Familial cardiac myxoma. A study of relatives of patients with myxoma . Chest 1994;105:65-8. https://doi.org/10.1378/chest.105.1.65 
  24. Gerbode F, Kerth WJ, Hill JD. Surgical management of tumors of the heart. Surgery 1967;61:94-101.